All endpoints met Significant improvements in itch and quality of life Significant control of staph bacteria-associated and other AD flares Clearance of infected AD skin Significant improvements in inflammation ANNAPOLIS, Md., March 7, 2024 /PRNewswire/ — Alphyn, a clinical-stage…